ML261: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving ML261

• A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
  NCT07488923 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations

Common questions

How many recruiting trials involve ML261?

1 recruiting trial across 6 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.